Becton Dickinson LSR II Analytical Flow Cytometer
Becton Dickinson LSR II Analytical Flow Cytometer
批准号:
8052222
负责人:
Raphael A. Clynes
金额:
$41.32万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-04 至 2012-04-03
关键词:
AccountingArterial Fatty StreakAtherosclerosisBiological AssayBlood CellsCell CycleCell LineageCellsCommunitiesComplexCore FacilityCytometryDetectionDevelopmentEnzyme-Linked Immunosorbent AssayEquipmentFlow CytometryFundingGene ExpressionGraft RejectionHeadImage CytometryImmunologistImmunologyInflammationInflammatoryInsulin-Dependent Diabetes MellitusLasersMaintenanceMalignant neoplasm of lungMedicineMyeloid Progenitor CellsPopulationPrimary Cell CulturesProteinsResearchResearch PersonnelResolutionResource SharingSamplingSideSignal TransductionSumSuppressor-Effector T-LymphocytesTechniquesTherapeuticTimeTissuesTrafficking Protein GeneTrainingTranslational ResearchTransplantation ToleranceUnited States National Institutes of Healthbasecancer transplantationcytokinehigh throughput analysisimmunoglobulin receptormedical schoolsmultidisciplinaryrelease of sequestered calcium ion into cytoplasmtooltranslational studyuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Flow cytometry has become the essential tool for cell-based assays. Yet these versatile machines are technologically complex and the equipment expensive requiring shared use and the development of core facilities. Currently, the Department of Medicine (25 different NIH-funded users) accounts for the majority of the campus-wide use of flow cytometry. The increased demand from the Department of Medicine and elsewhere at CUMC has justified the development of an internally funded Imaging and Cytometry Core, headed by Dr. Clynes. This is part of a larger institutional effort to build translational research in medicine, including the newly created Center of Translational Immunology. This proposal, in particular, joins 8 multidisciplinary biomedical researchers (whose NIH funded research totals >$15,000,000/year), and seeks to integrate immunologists with specific expertise in flow cytometric techniques with investigators studying inflammation in cancer, the lung, and the atheromatous plaque. This will create a shared resource for use, training, maintenance and of the versatile LSR II flow cytometer throughout the School of Medicine at CUMC. Examples of NIH funded research that this Core will support include: stem cells/myeloid suppressor cells in cancer, transplantation rejection and tolerance, resolution of atherosclerosis and therapeutic blockade of immunoglobulin receptors in type I diabetes. The requested LSR II requires three optional and costly accessories to permit and expedite these translational studies. 1. The UV laser permits immunoreceptor signaling (calcium flux), side population detection, and cell cycle analysis. 2. The yellow-green laser broadens the cytometers capacity to detect a wide variety of red flourochromes, including Red Flourescence Protein, important for cell lineage analysis, gene expression and protein trafficking, dramatically increasing versatility. 3. The 96-well attachment will allow high throughput analysis of CFSE proliferation assays, multiple analytes, expediting assessment of inflammatory cytokines in large sample format of tissue cells/blood and cultured primary cells eliminating the need for time-consuming ELISA based assays. In sum the LSRII will catalyze the development of a versatile and user-friendly Cytometry Core for over 25 NIH-funded investigators in the Department of Medicine and will make manifest the integration of the Center of Translational Immunology within the general community of the School of Medicine.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/ajt.13325
发表时间:
2015-10
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Zuber J, Rosen S, Shonts B, Sprangers B, Savage TM, Richman S, Yang S, Lau SP, DeWolf S, Farber D, Vlad G, Zorn E, Wong W, Emond J, Levin B, Martinez M, Kato T, Sykes M]
通讯作者:
Sykes M
DOI:
10.1038/s41564-019-0597-0
发表时间:
2020-01
期刊:
Nature microbiology
影响因子:
28.3
作者:
[]
通讯作者:
Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
过体扩展的受体调节T细胞对cynomolgus猕猴中MHC障碍的造血嵌合体和肾脏同种异体耐受性的影响。
DOI:
10.1097/tp.0000000000001559
发表时间:
2017-02
期刊:
Transplantation
影响因子:
6.2
作者:
[Duran-Struuck R, Sondermeijer HP, Bühler L, Alonso-Guallart P, Zitsman J, Kato Y, Wu A, McMurchy AN, Woodland D, Griesemer A, Martinez M, Boskovic S, Kawai T, Cosimi AB, Yang YG, Hu Z, Wuu CS, Slate A, Mapara M, Baker S, Tokarz R, D'Agati V, Hammer S, Pereira M, Lipkin WI, Wekerle T, Levings M, Sykes M]
通讯作者:
Sykes M
DOI:
10.1111/ajt.16333
发表时间:
2021-04
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
[Habal MV, Miller AMI, Rao S, Lin S, Obradovic A, Khosravi-Maharlooei M, See SB, Roy P, Shihab R, Ho SH, Marboe CC, Naka Y, Takeda K, Restaino S, Han A, Mancini D, Givertz M, Madsen JC, Sykes M, Addonizio LJ, Farr MA, Zorn E]
通讯作者:
Zorn E
DOI:
10.4049/jimmunol.1700257
发表时间:
2018-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Turner DL, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, Cao M, Dave R, Tanna N, D'Armiento JM, Farber DL]
通讯作者:
Farber DL
共 14 条
Enhancing the vaccinal effect of antitumor antibodies
-
批准号:8221960
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2012
-
负责人:Raphael A. Clynes
-
依托单位:
Enhancing the vaccinal effect of antitumor antibodies
-
批准号:8462945
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2012
-
负责人:Raphael A. Clynes
-
依托单位:
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
-
批准号:8602744
-
项目类别:
-
资助金额:$52.16万
-
财政年份:2011
-
负责人:Raphael A. Clynes
-
依托单位:
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
-
批准号:8041776
-
项目类别:
-
资助金额:$61.93万
-
财政年份:2011
-
负责人:Raphael A. Clynes
-
依托单位:
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
-
批准号:8403543
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2011
-
负责人:Raphael A. Clynes
-
依托单位:
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab
-
批准号:8209242
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2011
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:8034947
-
项目类别:
-
资助金额:$10.03万
-
财政年份:2010
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:7786689
-
项目类别:
-
资助金额:$57.26万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:8468695
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:8284465
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:8073511
-
项目类别:
-
资助金额:$58.42万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:7938980
-
项目类别:
-
资助金额:$62.09万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Type 1 Diabetes TrialNet: Clinical Center at Berrie Center, Columbia University
-
批准号:8831773
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2009
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7452515
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7651202
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7145517
-
项目类别:
-
资助金额:$32.24万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7384185
-
项目类别:
-
资助金额:$3.81万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7260439
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Abs in Autoimmune Diabetes
-
批准号:7856336
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2006
-
负责人:Raphael A. Clynes
-
依托单位:
Pathogenic Role of Islet Cell Autoantibodies in Type I Diabetes
-
批准号:8278713
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2005
-
负责人:Raphael A. Clynes
-
依托单位: